Vanguard Group’s Ocugen OCGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $22.2M | Buy |
16,475,562
+1,251,977
| +8% | +$1.78M | ﹤0.01% | 2571 |
|
|
2025
Q3 | $24.8M | Buy |
15,223,585
+450,904
| +3% | +$500K | ﹤0.01% | 2521 |
|
|
2025
Q2 | $14.3M | Sell |
14,772,681
-1,910,432
| -11% | -$1.58M | ﹤0.01% | 2718 |
|
|
2025
Q1 | $11.8M | Buy |
16,683,113
+64,020
| +0.4% | +$44.3K | ﹤0.01% | 2757 |
|
|
2024
Q4 | $13.4M | Sell |
16,619,093
-329,926
| -2% | -$302K | ﹤0.01% | 2795 |
|
|
2024
Q3 | $16.8M | Buy |
16,949,019
+1,427,852
| +9% | +$1.96M | ﹤0.01% | 2675 |
|
|
2024
Q2 | $24.1M | Buy |
15,521,167
+3,521,616
| +29% | +$5.49M | ﹤0.01% | 2474 |
|
|
2024
Q1 | $19.7M | Sell |
11,999,551
-40,367
| -0.3% | -$33.8K | ﹤0.01% | 2607 |
|
|
2023
Q4 | $6.92M | Buy |
12,039,918
+114,366
| +1% | +$45.8K | ﹤0.01% | 3146 |
|
|
2023
Q3 | $4.77M | Buy |
11,925,552
+119,207
| +1% | +$58.9K | ﹤0.01% | 3269 |
|
|
2023
Q2 | $6.41M | Sell |
11,806,345
-1,208,505
| -9% | -$775K | ﹤0.01% | 3186 |
|
|
2023
Q1 | $11.1M | Buy |
13,014,850
+1,155,707
| +10% | +$1.26M | ﹤0.01% | 2878 |
|
|
2022
Q4 | $15.4M | Buy |
11,859,143
+157,591
| +1% | +$246K | ﹤0.01% | 2752 |
|
|
2022
Q3 | $20.8M | Buy |
11,701,552
+283,751
| +2% | +$706K | ﹤0.01% | 2606 |
|
|
2022
Q2 | $25.9M | Buy |
11,417,801
+511,244
| +5% | +$1.22M | ﹤0.01% | 2520 |
|
|
2022
Q1 | $36M | Buy |
10,906,557
+301,063
| +3% | +$1.06M | ﹤0.01% | 2466 |
|
|
2021
Q4 | $48.3M | Sell |
10,605,494
-268,393
| -2% | -$2.03M | ﹤0.01% | 2374 |
|
|
2021
Q3 | $78.1M | Buy |
10,873,887
+486,356
| +5% | +$3.57M | ﹤0.01% | 2122 |
|
|
2021
Q2 | $83.4M | Buy |
10,387,531
+2,283,004
| +28% | +$19.3M | ﹤0.01% | 2088 |
|
|
2021
Q1 | $55M | Sell |
8,104,527
-970,466
| -11% | -$6.45M | ﹤0.01% | 2262 |
|
|
2020
Q4 | $16.6M | Buy |
9,074,993
+1,637,426
| +22% | +$789K | ﹤0.01% | 2732 |
|
|
2020
Q3 | $2.31M | Buy |
7,437,567
+7,108,182
| +2,158% | +$2.72M | ﹤0.01% | 3444 |
|
|
2020
Q2 | $73K | Hold |
329,385
| – | – | ﹤0.01% | 4008 |
|
|
2020
Q1 | $93K | Buy |
329,385
+167,281
| +103% | +$83.1K | ﹤0.01% | 3953 |
|
|
2019
Q4 | $84K | Buy |
162,104
+145,446
| +873% | +$145K | ﹤0.01% | 4020 |
|
|
2019
Q3 | $48K | Hold |
16,658
| – | – | ﹤0.01% | 4087 |
|
|
2019
Q2 | $191K | Sell |
16,658
-40,425
| -71% | -$457K | ﹤0.01% | 3985 |
|
|
2019
Q1 | $396K | Buy |
57,083
+26,336
| +86% | +$225K | ﹤0.01% | 3815 |
|
|
2018
Q4 | $163K | Buy |
30,747
+15,494
| +102% | +$494K | ﹤0.01% | 3930 |
|
|
2018
Q3 | $499K | Sell |
15,253
-133
| -0.9% | -$15.4K | ﹤0.01% | 3853 |
|
|
2018
Q2 | $2.31M | Buy |
15,386
+9
| +0.1% | +$1.4K | ﹤0.01% | 3456 |
|
|
2018
Q1 | $2.54M | Buy |
15,377
+8,904
| +138% | +$1.42M | ﹤0.01% | 3377 |
|
|
2017
Q4 | $796K | Buy |
6,473
+822
| +15% | +$101K | ﹤0.01% | 3659 |
|
|
2017
Q3 | $671K | Buy |
5,651
+1,022
| +22% | +$115K | ﹤0.01% | 3687 |
|
|
2017
Q2 | $500K | Hold |
4,629
| – | – | ﹤0.01% | 3727 |
|
|
2017
Q1 | $481K | Buy |
+4,629
| New | +$467K | ﹤0.01% | 3761 |
|
Other funds holding OCGN
Vanguard Group's OCGN Position: Q4 2025 in Review
Vanguard Group increased its Ocugen (OCGN) stake by 8.2% in Q4 2025, buying an estimated $1.78M and bringing the position to 16,475,562 shares worth $22.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2571.
Vanguard Group first reported a position in OCGN in Q1 2017 and has held it in 36 quarters since. The position peaked at $83.4M in Q2 2021. 109 funds tracked by Wall St. Rank hold OCGN as of Q4 2025.
- Vanguard Group held 16,475,562 shares of Ocugen worth $22.2M as of Q4 2025.
- Vanguard Group bought 1,251,977 Ocugen shares in Q4 2025, an estimated $1.78M.
- Ocugen made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2571 holding.
- Vanguard Group first reported a position in Ocugen in Q1 2017 and has held it in 36 quarters since.
- Vanguard Group's Ocugen position peaked at $83.4M in Q2 2021.
- 109 funds tracked by Wall St. Rank held Ocugen as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.